Comparative immunogenicity and safety of human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine and HPV 6/11/16/18 vaccine administered according to 2-and 3-dose schedules in girls aged 9-14 years: results to month 12 from a randomized trial

Estás aquí:
Ir a Tienda